Works matching DE "CHRONIC lymphocytic leukemia treatment"
Results: 599
Adoptive T-Cell Immunotherapy: One Step Forward.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 11, p. 1
- By:
- Publication type:
- Article
Are Prognostic Factors in CLL Overrated?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 8, p. 703
- By:
- Publication type:
- Article
Choose TREANDA for front-line treatment of CLL.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 103
- Publication type:
- Article
Bendamustine Study Demonstrates Significant Improvement in Overall Response and Progression- Free Survival in CLL Patients.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 850
- Publication type:
- Article
FDA Extends Review of Ofatumumab.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 810
- Publication type:
- Article
Rituximab, Fludarabine, and Cyclophosphamide Prolongs Progression-Free Survival in Relapsed or Refractory Chronic Lymphocytic Leukemia.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 14, p. 1578
- Publication type:
- Article
Seventy Percent of Complete Responders Remain in Continuous Remission: 5-Year Follow-Up of 300 Patients Treated With Fludarabine, Cyclophosphamide, and Rituximab (FCR) as Initial Therapy of CLL.
- Published in:
- 2007
- Publication type:
- Abstract
Salvage Therapy Following Failure or Relapse After FCR Chemo- Immunotherapy as Initial Treatment for Chronic Lymphocytic Leukemia.
- Published in:
- 2007
- Publication type:
- Abstract
Chronic lymphocytic leukaemia in the cat: 18 cases (2000-2010).
- Published in:
- Veterinary & Comparative Oncology, 2013, v. 11, n. 4, p. 256, doi. 10.1111/j.1476-5829.2011.00315.x
- By:
- Publication type:
- Article
FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR): A NEW STANDARD FOR CLL THERAPY.
- Published in:
- 2004
- Publication type:
- Abstract
CLL--FROM PALLIATION TO CURE?
- Published in:
- 2004
- Publication type:
- Abstract
NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA AND LYMPHOMA.
- Published in:
- 2004
- Publication type:
- Abstract
Selective toxicity of persian gulf sea cucumber holothuria parva on human chronic lymphocytic leukemia b lymphocytes by direct mitochondrial targeting.
- Published in:
- Environmental Toxicology, 2017, v. 32, n. 4, p. 1158, doi. 10.1002/tox.22312
- By:
- Publication type:
- Article
Chronic Lymphocytic Leukemia. From Diagnosis to Treatment Decision.
- Published in:
- Medicina Moderna, 2014, v. 21, n. 4, p. 304
- By:
- Publication type:
- Article
Navigating Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 9, p. 278
- Publication type:
- Article
Physical, Psychological, Social, and Spiritual Well-Being of Patients with Chronic Lymphocytic Leukemia and Their Caregivers: A Scoping Review.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2021, v. 12, n. 6, p. 182
- By:
- Publication type:
- Article
Oral Fludarabine.
- Published in:
- Drugs, 2003, v. 63, n. 21, p. 2317, doi. 10.2165/00003495-200363210-00004
- By:
- Publication type:
- Article
Oral Fludarabine: A Viewpoint by Dieter Huhn.
- Published in:
- Drugs, 2003, v. 63, n. 21, p. 2324, doi. 10.2165/00003495-200363210-00005
- By:
- Publication type:
- Article
Oral Fludarabine: A Viewpoint by David Oscier.
- Published in:
- Drugs, 2003, v. 63, n. 21, p. 2324, doi. 10.2165/00003495-200363210-00006
- By:
- Publication type:
- Article
Oral Fludarabine: A Viewpoint by Bruce D. Cheson.
- Published in:
- Drugs, 2003, v. 63, n. 21, p. 2324, doi. 10.2165/00003495-200363210-00007
- By:
- Publication type:
- Article
Rituximab: A Review of its Use in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia.
- Published in:
- Drugs, 2003, v. 63, n. 8, p. 803, doi. 10.2165/00003495-200363080-00005
- By:
- Publication type:
- Article
Bilateral Auricular Involvement: A Rare Presenting Sign of Chronic Lymphocytic Leukemia, and Successful Treatment with Electron Beam Therapy.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Allogenic bone marrow transplantation in chronic lymphocytic leukemia.
- Published in:
- 1996
- By:
- Publication type:
- commentary
Allogeneic bone marrow transplantation in chronic lymphocytic leukemia.
- Published in:
- 1996
- By:
- Publication type:
- commentary
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic...
- Published in:
- Annals of Internal Medicine, 1996, v. 124, n. 3, p. 311, doi. 10.7326/0003-4819-124-3-199602010-00005
- By:
- Publication type:
- Article
The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review.
- Published in:
- Advances in Hematology, 2024, v. 2024, p. 1, doi. 10.1155/2024/1370364
- By:
- Publication type:
- Article
Pharmacokinetics, efficacy and safety of the rituximab biosimilar CT-P10.
- Published in:
- Expert Review of Clinical Pharmacology, 2017, v. 10, n. 9, p. 923, doi. 10.1080/17512433.2017.1359537
- By:
- Publication type:
- Article
Drugs in Clinical Development for Chronic Lymphocytic Leukaemia: Summary and Table.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 5, p. 285, doi. 10.1007/s40290-015-0118-2
- Publication type:
- Article
Role of synthetic retinoic acid derivative in Chronic Lymphocytic Leukemia and Multiple Myeloma.
- Published in:
- BMC Proceedings, 2013, v. 7, n. Suppl 1, p. 1, doi. 10.1186/1753-6561-7-S1-O3
- By:
- Publication type:
- Article
Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
208 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) With Complex Karyotype, Clinic-Pathological Study and Risk for Richter Transformation.
- Published in:
- American Journal of Clinical Pathology, 2018, v. 149, p. S88, doi. 10.1093/ajcp/aqx121.207
- By:
- Publication type:
- Article
Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma presenting simultaneously with acquired hemophilia and warm autoimmune hemolytic anemia.
- Published in:
- Baylor University Medical Center Proceedings, 2017, v. 30, n. 3, p. 343, doi. 10.1080/08998280.2017.11929642
- By:
- Publication type:
- Article
Idelalisib.
- Published in:
- Australian Prescriber, 2016, v. 39, n. 2, p. 60, doi. 10.18773/austprescr.2016.010
- Publication type:
- Article
Ibrutinib.
- Published in:
- Australian Prescriber, 2015, v. 38, n. 5, p. 178, doi. 10.18773/austprescr.2015.065
- Publication type:
- Article
Approved indication: B cell chronic lymphocytic leukaemia.
- Published in:
- Australian Prescriber, 2015, v. 38, n. 4, p. 141
- Publication type:
- Article
Case Report of Unexpectedly Long Survival of Patient With Chronic Lymphocytic Leukemia: Why Integrative Methods Matter.
- Published in:
- Integrative Medicine: A Clinician's Journal, 2018, v. 17, n. 1, p. 51
- By:
- Publication type:
- Article
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Recent advances in chronic lymphocytic leukemia.
- Published in:
- Indian Journal of Cancer, 2012, v. 49, n. 1, p. 137, doi. 10.4103/0019-509X.98940
- By:
- Publication type:
- Article
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 91, doi. 10.1007/s00262-016-1922-6
- By:
- Publication type:
- Article
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 665, doi. 10.1007/s00262-015-1670-z
- By:
- Publication type:
- Article
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2367, doi. 10.1007/s00262-012-1362-x
- By:
- Publication type:
- Article
CLL11 Study: 5-Year Results Confirm Obinutuzumab plus Chemotherapy as Front-Line Therapy for Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Value-Based Cancer Care, 2018, v. 9, n. 3, p. 24
- By:
- Publication type:
- Article
Ibrutinib plus Venetoclax Combo Elicits Impressive Responses in Relapsed Chronic Lymphocytic Leukemia.
- Published in:
- Value-Based Cancer Care, 2018, v. 9, n. 1, p. 19
- By:
- Publication type:
- Article
First-Line Ibrutinib Improves Outcomes Compared with Current Standard of Care in Older Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 2, p. 33
- By:
- Publication type:
- Article
Researchers Identify First Mutation to Explain Resistance to Venetoclax.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 2, p. 30
- By:
- Publication type:
- Article
Researchers Identify First Mutation to Explain Resistance to Venetoclax.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 1, p. 14
- By:
- Publication type:
- Article
Paradigm Shift: Ibrutinib plus Rituximab Front-Line Therapy for Patients with CLL Under Age 70.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 1, p. 1
- By:
- Publication type:
- Article
CLL11 Study: 5-Year Results Confirm Obinutuzumab plus Chemotherapy as Front-Line Therapy for Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 8, p. 17
- By:
- Publication type:
- Article
Venetoclax plus Rituximab New Chemotherapy-Free Option for Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 23
- By:
- Publication type:
- Article